Valuation: Danaher Corporation

Market Cap 137B 121B 111B 103B 195B 13,160B 199B 1,338B 520B 6,440B 516B 505B 22,356B P/E 2026 *
30.9x
P/E 2027 * 25.5x
Enterprise Value 137B 121B 111B 103B 195B 13,160B 199B 1,338B 520B 6,440B 516B 505B 22,356B EV / Sales 2026 *
5.27x
EV / Sales 2027 * 4.84x
Free-Float
71.14%
Yield 2026 *
0.75%
Yield 2027 * 0.79%
1 day-1.74%
1 week-1.57%
Current month+0.10%
1 month+3.89%
3 months-2.81%
6 months-18.86%
Current year-16.71%
1 week 189.78
Extreme 189.78
198.23
1 month 174.22
Extreme 174.2162
198.23
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2020
Director of Finance/CFO - 27/02/2026
Chief Tech/Sci/R&D Officer - 24/08/2025
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1983
Director/Board Member 69 31/12/1983
Date Insider Type Main position Quantity % Market Cap.
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.81%-1.57%-4.99%-18.68% 137B
-1.53%-0.91%+19.36%-1.58% 192B
-2.51%+3.74%-20.83%+22.68% 151B
-1.67%+3.50%-56.48%-15.44% 67.33B
-1.51%+1.55%+22.29%+1.94% 54.6B
-2.84%-0.67%-26.99%-31.10% 44.94B
-1.44%-1.90%+6.66%+40.15% 36.81B
-1.76%-3.33%+6.56%+8.95% 37.04B
-6.37%+2.92%-19.34%-4.45% 31.7B
-0.54%-0.48%-14.16%-19.97% 29.52B
Average -2.12%+4.08%-8.79%-1.75% 78.27B
Weighted average by Cap. -1.95%+3.98%-5.70%-0.88%

Financials

2026 *2027 *
Net sales 26.06B 22.85B 21.1B 19.5B 36.96B 2,495B 37.69B 254B 98.55B 1,221B 97.85B 95.7B 4,238B 28.37B 24.88B 22.97B 21.23B 40.24B 2,717B 41.05B 276B 107B 1,329B 107B 104B 4,615B
Net income 4.42B 3.87B 3.58B 3.3B 6.26B 423B 6.39B 42.99B 16.71B 207B 16.59B 16.22B 718B 5.35B 4.69B 4.33B 4B 7.58B 512B 7.74B 52.06B 20.23B 251B 20.08B 19.64B 870B
Net Debt - -
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
08/07/26 US$190.65 -1.82% 1,491,910
07/07/26 US$194.19 +0.29% 3,248,899
06/07/26 US$193.62 -2.18% 4,663,821
02/07/26 US$197.93 +2.17% 4,035,515
01/07/26 US$193.72 +1.70% 4,515,633
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
194.19USD
Average target price
242.26USD
Spread / Average Target
+24.75%

Quarterly revenue - Rate of surprise